These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 170856)

  • 61. Ceftazidime combined with mecillinam: serum bactericidal titres compared with in-vitro synergy against gram-negative bacilli.
    Van der Auwera P; Vandermies A; Lieppe S; Grenier P; Bourguignon AM; Ernst F
    J Antimicrob Chemother; 1988 Jun; 21(6):745-53. PubMed ID: 3045067
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Sensitivity to FL 1060 (mecilliman) of E. coli and Klebsiella pneumoniae isolated from bile (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1980 Mar; 33(3):329-32. PubMed ID: 6249943
    [No Abstract]   [Full Text] [Related]  

  • 63. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
    Chattopadhyay B; Hall I
    J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
    Pfaller M; Barry A; Fuchs P; Gerlach E; Hardy D; McLaughlin J
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):200-5. PubMed ID: 8389705
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Sensitivity of Enterobacteriaceae isolated from humans to 6-N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX)].
    Zaremba M; Zukowska-Nytko K; Grala-Kałuzna A; Kacprzak-Wiatr A; Piotrowski J; Kulikowska A; borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):17-26. PubMed ID: 6292593
    [No Abstract]   [Full Text] [Related]  

  • 66. Mecillinam susceptibility of Escherichia coli K-12 mutants deficient in the adenosine 3',5'-monophosphate system.
    Scott NW; Harwood CR
    Antimicrob Agents Chemother; 1981 Apr; 19(4):540-4. PubMed ID: 6264850
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasmid-mediated partial cross-resistance between ampicillin, mecillinam and cefamandole in Salmonella johannesburg and Salmonella typhimurium.
    Chau PY; Ng WS; Ling J; Arnold K
    J Antimicrob Chemother; 1981 Mar; 7(3):245-55. PubMed ID: 6268597
    [No Abstract]   [Full Text] [Related]  

  • 68. Pharmacokinetics of pivmecillinam.
    Parsons RL; Hossack GA; Paddock GM
    Br J Clin Pharmacol; 1977 Jun; 4(3):267-73. PubMed ID: 197981
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.
    Retsema JA; English AR; Girard AE
    Antimicrob Agents Chemother; 1980 Apr; 17(4):615-22. PubMed ID: 6249192
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mecillinam and ampicillin separately or combined in gram-negative septicemia.
    Ekwall E; Scheja A; Cronberg S; Ganrot-Norlin K; Jonsson M; Juhlin I; Kahlmeter G; Thorén A; Thulin KE; Tunevall G
    Infection; 1980; 8(1):37-40. PubMed ID: 6246006
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Virulence of mecillinam-resistant spherical mutants of Klebsiella pneumoniae and Escherichia coli.
    Verweij-van Vught AM; Namavar F; Smit AM; Sparrius M; MacLaren DM
    J Antimicrob Chemother; 1982 May; 9(5):379-85. PubMed ID: 6284694
    [No Abstract]   [Full Text] [Related]  

  • 72. Comparison of in vitro activity of mecillinam with other antimicrobial chemotherapeutic agents against Salmonella Shigella and El Tor Vibrio cholerae.
    Mhalu FS; Swai V; Runyoro D; Shao JF
    East Afr Med J; 1982 Oct; 59(10):676-81. PubMed ID: 6309499
    [No Abstract]   [Full Text] [Related]  

  • 73. Effect of urine concentration versus tissue concentration of ampicillin and mecillinam on bacterial adherence in the rat bladder.
    Frimodt-Møller N; Maigaard S; Madsen PO
    Invest Urol; 1981 Mar; 18(5):322-5. PubMed ID: 6259079
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillin.
    Butler T; Shuster CW; Dixon P
    Antimicrob Agents Chemother; 1981 Feb; 19(2):328-31. PubMed ID: 6289730
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A mecillinam-sensitive peptidoglycan crosslinking reaction in Escherichia coli.
    Ishino F; Tamaki S; Spratt BG; Matsuhashi M
    Biochem Biophys Res Commun; 1982 Dec; 109(3):689-96. PubMed ID: 6297485
    [No Abstract]   [Full Text] [Related]  

  • 76. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
    Neu HC
    Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epicillin: in vitro laboratory studies.
    Basch H; Erickson R; Gadebusch H
    Infect Immun; 1971 Jul; 4(1):44-9. PubMed ID: 4343402
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical pharmacology of mecillinam in calves.
    Soback S; Bor A; Paz R; Ziv G
    J Vet Pharmacol Ther; 1986 Dec; 9(4):385-93. PubMed ID: 3543397
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sensitivities of clinically significant organisms to four cephalosporins, ampicillin and mecillinam.
    Rahman M
    Curr Med Res Opin; 1980; 7(2):96-100. PubMed ID: 6254727
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. II. Antibacterial properties.
    Angehrn P; Arisawa M
    J Antibiot (Tokyo); 1982 Nov; 35(11):1584-9. PubMed ID: 6298168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.